Traws Pharma, Inc.
TRAW
$0.54
-$0.01-2.26%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.01% | 86.13% | 105.51% | 90.55% | 87.00% |
| Total Depreciation and Amortization | 2,350.00% | 1,055.56% | 408.33% | 35.71% | -64.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 252.43% | -98.88% | -118.03% | -101.25% | -101.08% |
| Change in Net Operating Assets | 133.45% | 136.54% | 76.01% | 43.19% | -56.38% |
| Cash from Operations | 37.44% | 50.25% | 38.96% | 35.50% | -16.21% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 29.14% | 29.14% | 29.14% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -39.12% | -78.40% | -83.49% | 67.78% | 66.95% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -891.99% | -1,754.47% | -- | -- | -- |
| Cash from Financing | -50.69% | -85.03% | -90.57% | 64.46% | 64.90% |
| Foreign Exchange rate Adjustments | -133.33% | 54.55% | 352.63% | 1,400.00% | 940.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -111.96% | -2,726.49% | -3,488.39% | 105.09% | 70.37% |